Previous close | 143.99 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 142.25 - 143.38 |
52-week range | 87.51 - 143.38 |
Volume | |
Avg. volume | 2,025 |
Market cap | 254.771M |
Beta (5Y monthly) | 1.08 |
PE ratio (TTM) | 0.61 |
EPS (TTM) | 2.32 |
Earnings date | 31 July 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Does Xylem (XYL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Xylem Inc. (XYL) continued its streak of surpassing revenue expectations.
Xylem (XYL) benefits from strength in the M&CS segment and the acquisition of Evoqua. Its measures to reward its shareholders are encouraging.